← Back to search
Literature record

A homozygous variant in FGFR3 causing lethal skeletal dysplasia.

PMID 41756230 | PMCID PMC12934494 | DOI 10.24911/SJP.106-1759127221 · Sudanese journal of paediatrics · 2025 · View on PubMed ↗

Homozygous achondroplasia, due to biallelic pathogenic Fibroblast Growth Factor Receptor 3 (FGFR3) variants, is the homozygous lethal expression of an autosomal dominant skeletal dysplasia and is clinically distinct from the classical heterozygous form. We describe a male infant born to two achondroplastic heterozygous parents with severe rhizomelic shortening and radiographic features typical of homozygous achondroplasia. Molecular analysis revealed a homozygous c.1138G>A (p.Gly380Arg) variant in FGFR3. The infant developed progressive respiratory compromise and died at 63 days of age due to pulmonary hypoplasia-related respiratory failure.

Validated evidence

TypeEntitySource evidenceConfidenceExtractor
geneFGFR3“A homozygous variant in FGFR3 causing lethal skeletal dysplasia.”0.98hgnc_dict_v1
phenotypeskeletal dysplasia“A homozygous variant in FGFR3 causing lethal skeletal dysplasia.”0.98phenotype_alias_lexicon_v2
variantc.1138G>A“Molecular analysis revealed a homozygous c.1138G>A (p.Gly380Arg) variant in FGFR3.”0.95hgvs_regex_v1
variantp.Gly380Arg“Molecular analysis revealed a homozygous c.1138G>A (p.Gly380Arg) variant in FGFR3.”0.95hgvs_regex_v1